HIGH GRADE MENINGIOMA

Clinical trials for HIGH GRADE MENINGIOMA explained in plain language.

Never miss a new study

Get alerted when new HIGH GRADE MENINGIOMA trials appear

Sign up with your email to follow new studies for HIGH GRADE MENINGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Immunotherapy drug shows promise for tough brain tumor

Disease control Ongoing

This study tested the immunotherapy drug pembrolizumab in 26 people with high grade meningioma that came back or remained after treatment. The goal was to see if the drug could stop the tumor from growing for at least 6 months. Participants received pembrolizumab and had regular …

Matched conditions: HIGH GRADE MENINGIOMA

Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

HIGH GRADE MENINGIOMA

Get alerted when new HIGH GRADE MENINGIOMA trials appear

Immunotherapy drug shows promise for tough brain tumor